MAGEA1 and ovarian carcinoma: With respect to EOC, the frequency of MAGE-A1 and -A3 expression that we report is similar to that reported in previous studies, with the exception of Zhang et al who found a 54% and 37% expression in ovarian cancer tissues, respectively [28]–[30].